From: CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
Pre-dosing | Post-dosing | |
---|---|---|
IL-4 | 3.31 | 32.78 |
IL-5 | 3.11 | 5.56 |
IL-6 | 0 | 181.45 |
IL-10 | 0 | 67.26 |
IL-13 | 0 | 122.46 |
IL-17 | 4.34 | 4 |
TNF-α | 0 | 294.85 |
INF-γ | 4.32 | 5.77 |
MCP-1 | 0 | 811.45 |
RANTES | 102.67 | 141.16 |